Scholarly Index
Adil Daud
University of California, San Francisco; 48,097 total citations; 461 total publications; best world rank #61
University of California, San Francisco
48,097Total citations
461Total publications
88H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 112 | US 65 | 99.71 |
| CAR-T cell therapy research | Lifetime | 94 | US 55 | 99.64 |
| Immunotherapy and Immune Responses | Lifetime | 396 | US 210 | 99.32 |
| Melanoma and MAPK Pathways | Lifetime | 61 | US 31 | 99.30 |
| Cutaneous Melanoma Detection and Management | Lifetime | 181 | US 76 | 98.61 |
| Histone Deacetylase Inhibitors Research | Lifetime | 381 | US 200 | 96.47 |
| HER2/EGFR in Cancer Research | Lifetime | 779 | US 348 | 96.90 |
| Protein Degradation and Inhibitors | Lifetime | 676 | US 332 | 95.50 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 871 | US 321 | 96.61 |
| CAR-T cell therapy research | 2021-2025 | 631 | US 348 | 96.27 |
| Melanoma and MAPK Pathways | 2021-2025 | 152 | US 46 | 92.01 |